Arca
Skip to content
Tools
Tools

ROCK2: Rho-associated protein kinase 2

Protein kinase which is a key regulator of actin cytoskeleton and cell polarity.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on ROCK2, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Belumosudil

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        BelumosudilApprovedSanofi-AventisSmall moleculeInhibitorRho-associated protein kinase 2 inhibitor19

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        Graft versus host disease
        0.55
        Neurodegenerative disease
        0.55
        Fuchs' endothelial dystrophy
        0.40
        Cardiovascular disorder
        0.38
        Immune system disorder
        0.37
        Basal cell carcinoma
        0.34
        Uterine corpus leiomyoma
        0.29
        Chronic lung allograft dysfunction
        0.26

        Genes and related targets

        Complexes and families that share a gene with this target
        Genes
        ROCK2

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2973, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt O75116, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.